Understanding T cell responses to COVID-19 is essential for informing public health strategies
Santosha A. Vardhana, Lance Baldo, William G. Morice, E. John Wherry
Abstract
Durable T cell responses to SARS-CoV-2 antigens after infection or vaccination improve immune-mediated viral clearance. To date, population-based surveys of COVID-19 adaptive immunity have focused on testing for IgG antibodies that bind spike protein and/or neutralize the virus. Deployment of existing methods for measuring T cell immunity could provide a more complete profile of immune status, informing public health policies and interventions.
Topics & Concepts
Immune systemImmunityVaccinationImmunologyAcquired immune systemCoronavirus disease 2019 (COVID-19)AntibodyVirologyPopulationVirusPublic healthBiologyAntigenMedicineEnvironmental healthDiseaseInfectious disease (medical specialty)NursingPathologySARS-CoV-2 and COVID-19 ResearchCOVID-19 Clinical Research Studiesvaccines and immunoinformatics approaches